Exercise and Pharmacological Treatment of Depressive Symptoms in Patients With Coronary Heart Disease

被引:207
作者
Blumenthal, James A. [1 ]
Sherwood, Andrew [1 ]
Babyak, Michael A. [1 ]
Watkins, Lana L. [1 ]
Smith, Patrick J. [1 ]
Hoffman, Benson M. [1 ]
O'Hayer, C. Virginia F. [1 ]
Mabe, Stephanie [1 ]
Johnson, Julie [1 ]
Doraiswamy, P. Murali [1 ]
Jiang, Wei [1 ]
Schocken, Douglas D. [2 ]
Hinderliter, Alan L. [3 ]
机构
[1] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[3] Univ N Carolina, Dept Med, Chapel Hill, NC USA
基金
美国国家卫生研究院;
关键词
antidepressant medication; biomarkers; depression; exercise; heart rate variability; SSRI; MYOCARDIAL-INFARCTION; RATE-VARIABILITY; ANTIDEPRESSANT TREATMENT; SEXUAL DYSFUNCTION; CARDIAC MORTALITY; MAJOR DEPRESSION; ARTERY-DISEASE; RISK-FACTOR; ASSOCIATION; EFFICACY;
D O I
10.1016/j.jacc.2012.04.040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aim of this study was to assess the efficacy of exercise and antidepressant medication in reducing depressive symptoms and improving cardiovascular biomarkers in depressed patients with coronary heart disease. Background Although there is good evidence that clinical depression is associated with poor prognosis, optimal therapeutic strategies are currently not well defined. Methods One hundred one outpatients with coronary heart disease and elevated depressive symptoms underwent assessment of depression, including a psychiatric interview and the Hamilton Rating Scale for Depression. Participants were randomized to 4 months of aerobic exercise (3 times/week), sertraline (50-200 mg/day), or placebo. Additional assessments of cardiovascular biomarkers included measures of heart rate variability, endothelial function, baroreflex sensitivity, inflammation, and platelet function. Results After 16 weeks, all groups showed improvement on Hamilton Rating Scale for Depression scores. Participants in both the aerobic exercise (mean -7.5; 95% confidence interval: -9.8 to -5.0) and sertraline (mean -6.1; 95% confidence interval: -8.4 to -3.9) groups achieved larger reductions in depressive symptoms compared with those receiving placebo (mean -4.5; 95% confidence interval: -7.6 to -1.5; p = 0.034); exercise and sertraline were equally effective at reducing depressive symptoms (p = 0.607). Exercise and medication tended to result in greater improvements in heart rate variability compared with placebo (p = 0.052); exercise tended to result in greater improvements in heart rate variability compared with sertraline (p = 0.093). Conclusions Both exercise and sertraline resulted in greater reductions in depressive symptoms compared to placebo in patients with coronary heart disease. Evidence that active treatments may also improve cardiovascular biomarkers suggests that they may have a beneficial effect on clinical outcomes as well as on quality of life. (Exercise to Treat Depression in Individuals With Coronary Heart Disease; NCT00302068) (J Am Coll Cardiol 2012;60:1053-63) (c) 2012 by the American College of Cardiology Foundation
引用
收藏
页码:1053 / 1063
页数:11
相关论文
共 48 条
[1]  
[Anonymous], DIAGN STAT MAN MENT
[2]   Depression as a risk factor for mortality in patients with coronary heart disease: A meta-analysis [J].
Barth, J ;
Schumacher, M ;
Herrmann-Lingen, C .
PSYCHOSOMATIC MEDICINE, 2004, 66 (06) :802-813
[3]  
Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106
[4]   Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial [J].
Blumenthal, JA ;
Babyak, MA ;
Carney, RM ;
Huber, M ;
Saab, PG ;
Burg, MM ;
Sheps, D ;
Powell, L ;
Taylor, CB ;
Kaufmann, PG .
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2004, 36 (05) :746-755
[5]   COMPARISON OF HIGH-INTENSITY AND LOW-INTENSITY EXERCISE TRAINING EARLY AFTER ACUTE MYOCARDIAL-INFARCTION [J].
BLUMENTHAL, JA ;
REJESKI, WJ ;
WALSHRIDDLE, M ;
EMERY, CF ;
MILLER, H ;
ROARK, S ;
RIBISL, PM ;
MORRIS, PB ;
BRUBAKER, P ;
WILLIAMS, RS .
AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (01) :26-30
[6]   Effects of exercise and stress management training on markers of cardiovascular risk in patients with ischemic heart disease - A randomized controlled trial [J].
Blumenthal, JA ;
Sherwood, A ;
Babyak, MA ;
Watkins, LL ;
Waugh, R ;
Georgiades, A ;
Bacon, SL ;
Hayano, J ;
Coleman, RE ;
Hinderliter, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (13) :1626-1634
[7]   Effects of exercise training on older patients with major depression [J].
Blumenthal, JA ;
Babyak, MA ;
Moore, KA ;
Craighead, E ;
Herman, S ;
Khatri, P ;
Waugh, R ;
Napolitano, MA ;
Forman, LM ;
Appelbaum, M ;
Doraiswamy, PM ;
Krishnan, KR .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (19) :2349-2356
[8]   Exercise and pharmacotherapy in the treatment of major depressive disorder [J].
Blumenthal, James A. ;
Babyak, Michael A. ;
Doraiswamy, P. Murali ;
Watkins, Lana ;
Hoffman, Benson M. ;
Barbour, Krista A. ;
Herman, Steve ;
Craighead, W. Edward ;
Brosse, Alisha L. ;
Waugh, Robert ;
Hinderliter, Alan ;
Sherwood, Andrew .
PSYCHOSOMATIC MEDICINE, 2007, 69 (07) :587-596
[9]   No Laughing Matter [J].
Blumenthal, James A. ;
O'Connor, Christopher .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (08) :836-836
[10]   The ELIXIR study:: evaluation of sexual dysfunction in 4557 depressed patients in France [J].
Bonierbale, M ;
Lançon, C ;
Tignol, J .
CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (02) :114-124